Open in App
  1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : PHARMACEUTICALS
  4. SYNCOM FORMULATION (INDIA) LTD.
Syncom Formulation (India) Ltd.
NSE: SYNCOMF | BSE: 524470 | ASM
Strong Performer, Getting Expensive
Download real time
Ask AI about Syncom Formulation
20.04 1.26 (6.71%)
96.28% Gain from 52W Low
11.0M
NSE+BSE Volume

NSE 18 Sep, 2026 3:31 PM (IST)

Watchlist

Portfolio

Alert
Dividend
Syncom Formulation has an upcoming dividend of ₹0.100 per share due on 23 Sep 2026 See details

Syncom Formulation quarterly and annual financials: results, revenue, profit, P&L, balance sheet, cash flow, financial ratios, revenue mix, peer comparison, and financial documents